About this episode
Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.
By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?
Guest:
Peter Aldhous, science reporter at Buzzfeed News
Host
Lizzie O’Leary
Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time What Next: TBD | Tech, power, and the future publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What Next: TBD | Tech, power, and the future
Meta Settled. Is it a "Reckoning?"
What Next: TBD | Tech, power, and the future
A.I. Enshittifies Everything (Still)
What Next: TBD | Tech, power, and the future
Can the Midterms Withstand Prediction Markets?
What Next: TBD | Tech, power, and the future
Are Flock Cameras Watching You?
What Next: TBD | Tech, power, and the future